News | PACS | June 23, 2017

Median Technologies and Medidata Partner to Deliver Differentiated Image Management Services in Clinical Trials

France-based organization to tap into Medidata platform that analyzes, captures and manages medical images to accelerate the development of new medicines in oncology

June 23, 2017 — Medidata and Median Technologies announced a new collaboration to streamline the growth and use of medical imaging in cancer clinical trials. Median Technologies will leverage the Medidata Clinical Cloud to accelerate the development of medicines in oncology with new, scalable image management services.

Imaging technologies are a major part of evaluating new patient treatments, allowing clinicians and sponsors to detect diseases, monitor outcomes and determine therapy responses. Median Technologies, a services provider of image interpretation and management in oncology trials, will leverage Medidata Medical Imaging to transition its legacy imaging study management systems to a single digital environment, gaining seamless access to configurable and intelligent image workflows, while still maintaining global regulatory standards.

"Our collaboration with Medidata will not only ease the management of images during clinical drug trials- it will enhance our analytical rigor, enabling our teams to extract high-quality imaging biomarkers for better study and patient outcomes," said Jeanne Hecht, Median Technologies' chief operating officer.

Medidata Medical Imaging provides superior workflow management and flexibility of image resources, according to the company, working seamlessly with proprietary technologies like Median. The collaboration will provide Median with the highest level of control and access to image data and performance metrics, while enabling automatic edit checks and de-identification.

For more information: www.mdsol.com

Related Content

News | PACS Accessories | February 22, 2018
The RamSoft team will showcase radiology solutions to help users cut costs and save time at the 2018 Healthcare...
Mirada Medical Releases DLCExpert for Radiotherapy Treatment Planning
Technology | Treatment Planning | February 22, 2018
February 22, 2018 — U.K.-based medical imaging software provider Mirada Medical has released DLCExpert, the first com
Sponsored Content | Videos | Pediatric Imaging | February 22, 2018
FUJIFILM Medical Systems U.S.A., Inc. and FUJIFILM SonoSite Inc., are offering a full-suite pediatric solutions...
Sponsored Content | Videos | Flat Panel Displays | February 21, 2018
This 5 megapixel, high-brightness color monitor has the high-definition display necessary for breast imaging.
Konica Minolta Exa Enterprise Imaging Delivers Intelligent Radiology Analytics
News | Enterprise Imaging | February 20, 2018
At the 2018 annual meeting of the Healthcare Information and Management Systems Society (HIMSS), March 5-9 in Las Vegas...
Mitchell Cancer Institute Selects RayStation for TomoTherapy Planning
News | Treatment Planning | February 16, 2018
The University of South Alabama Mitchell Cancer Institute (MCI) in Mobile, Ala., has selected RayStation as its...
A brain MRI. Gadolinium contrast agents (GBCAs) are partly retained in the brain, raising safety concerns.
Feature | Magnetic Resonance Imaging (MRI) | February 16, 2018 | Dave Fornell
One of the biggest concerns in radiology in recent years is the safety of gadolinium-based contrast agents (GBCAs) us
Radiography Education Enrollment Shows Marginal Rise in 2017
News | Business | February 15, 2018
Directors of radiography educational programs report the number of enrolled students increased slightly in 2017, while...
Sponsored Content | Videos | Imaging | February 15, 2018
David Widmann, president and CEO of Konica Minolta, looks at what the future of healthcare can bring to its customers,...
Overlay Init